These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10682234)

  • 1. Intravenous administration of levodopa ameliorated a refractory akathisia case induced by interferon-alpha.
    Sunami M; Nishikawa T; Yorogi A; Shimoda M
    Clin Neuropharmacol; 2000; 23(1):59-61. PubMed ID: 10682234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of polymyositis with dilated cardiomyopathy associated with interferon alpha treatment for hepatitis B.
    Lee SW; Kim KC; Oh DH; Jung SS; Yoo DH; Kim SY; Choe G; Kim TH
    J Korean Med Sci; 2002 Feb; 17(1):141-3. PubMed ID: 11850606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
    Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
    Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug treatments of levodopa-induced dyskinesias.
    Vale S
    Lancet; 1999 Aug; 354(9177):511. PubMed ID: 10465195
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B.
    Ketikoglou I; Karatapanis S; Elefsiniotis I; Kafiri G; Moulakakis A
    Eur J Dermatol; 2005; 15(2):107-9. PubMed ID: 15757824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis.
    Dalekos GN; Christodoulou D; Kistis KG; Zervou EK; Hatzis J; Tsianos EV
    Eur J Gastroenterol Hepatol; 1998 Nov; 10(11):933-9. PubMed ID: 9872615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of hepatitis B e antigen-positive chronic hepatitis B with pegylated interferon.
    Cooksley G
    J Hepatol; 2003; 39 Suppl 1():S143-5. PubMed ID: 14708693
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reversible Perimacular Retinopathy by Long-Time Interferon alpha Therapy].
    Sandner D; Pillunat LE
    Klin Monbl Augenheilkd; 2004 Jan; 221(1):63-6. PubMed ID: 14745683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death possibly associated with interferon use in a patient with chronic hepatitis.
    Kendirli T; Kismet E; Demirkaya E; Aydin HI; Kesik V; Köseoğlu V
    Acta Paediatr; 2005 Jul; 94(7):984-5. PubMed ID: 16188832
    [No Abstract]   [Full Text] [Related]  

  • 11. Rare complication of interferon alpha therapy: retinal vein thrombosis.
    Akyuz F; Akyuz U; Kocaman O; Kaymakoglu S
    Acta Gastroenterol Belg; 2005; 68(3):394-5. PubMed ID: 16268432
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of interferon alpha-induced manic psychosis in chronic hepatitis C.
    Kanno A; Yamada M; Abe M; Okamoto Y
    Tohoku J Exp Med; 1999 Jan; 187(1):79-82. PubMed ID: 10458496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of akathisia during interferon-alpha therapy for chronic hepatitis type C.
    Horikawa N; Yamazaki T; Sagawa M; Nagata T
    Gen Hosp Psychiatry; 1999; 21(2):134-5. PubMed ID: 10228895
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
    Ringwald E
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Nov; 11(6):294-8. PubMed ID: 33397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha and lamivudine combination therapy of children with chronic hepatitis b infection who were interferon-alpha nonresponders.
    Saltik-Temizel IN; Koçak N; Demir H
    Pediatr Infect Dis J; 2004 May; 23(5):466-8. PubMed ID: 15131475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.
    van Zonneveld M; Flink HJ; Verhey E; Senturk H; Zeuzem S; Akarca US; Cakaloglu Y; Simon C; So TM; Gerken G; de Man RA; Hansen BE; Schalm SW; Janssen HL;
    Aliment Pharmacol Ther; 2005 May; 21(9):1163-71. PubMed ID: 15854180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Elevation of liver enzymes in a patient with chronic hepatitis B during alpha-interferon treatment: what is it all about?].
    Tiesmeier J; Dienes HP; Schuppert F
    MMW Fortschr Med; 2009 Sep; 151(37):48-50. PubMed ID: 19827430
    [No Abstract]   [Full Text] [Related]  

  • 18. Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease.
    Clarke C E; Speller J M
    Cochrane Database Syst Rev; 2000; (2):CD000236. PubMed ID: 10796705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal adverse effects of interferon-alpha.
    Jankovic S
    Drug Saf; 2005; 28(7):647. PubMed ID: 15963011
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon-alpha treatment in children and young adults with chronic hepatitis B: a long-term follow-up study in Taiwan.
    Hsu HY; Tsai HY; Wu TC; Chiang CL; Ni YH; Chen PJ; Chang MH
    Liver Int; 2008 Nov; 28(9):1288-97. PubMed ID: 18397229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.